I really thought this stock would run on approval.. I mean run . A fast walk is ok but such a revolutionary drug deservers better...... If you read a label on any medication, they are all scary...This one is no different..
It will run when the sales beat all forcasts,
it will run when Afrezza can't be made fast enough,
it will run when we receive EU approval and start marketing,
it will run when AL sells at an incredible premium.
Then it's over.
You should read other label warnings, this was expected.
There is no patience anymore. Come back in 2-3 years, you'll see.